P/B
4,6
Thermo Fisher Scientific
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
$243.4B
Market Cap • 9/17/2026
1956
(70 years)
Founded
1972
(54 years ago)
IPO
NYSE
Listing Exchange
United States
Country
S&P500 Participant
Index Composite • 2026
Valuation
P/S
5,3
P/EBITDA
22
P/OCF
27
P/FCF
33,3
P/E
35,4
BVPS
140,6
EPS
18,6
Market Cap
Market Cap
243,4B
EV
282B
EV/Revenue
6,1
EV/EBITDA
25,4
EV/EBIT
34,6
Payout
Dividend Per Share
1,8
Dividend Yield
0,3%
Buyback Yield
2,1%
Total Yield
2,3%
Dividend Yield 5Y
0,3%
Payout
9,5%
Retained Earnings
62,2B
Profitability
Gross Margin
40,8%
EBITDA Margin
23,9%
EBIT Margin
17,6%
Net Margin
15,2%
D&A/EBITDA
0%
R&D/Revenue
3%
Capex/Revenue
3,7%
Capex/D&A
57,6%
Capex/OCF
18,8%
SBC/OCF
3,5%
% PPE
9,5%
% Goodwill
48,4%
ROE
13,6%
ROIC
8,3%
Growth
CAGR Revenue 5Y
3,9%
CAGR Op. Income 5Y
-5,3%
CAGR Net Income 5Y
-3,9%
CAGR EPS 5Y
-2,9%
CAGR OCF 5Y
-2,5%
Leverage
N.D./EBITDA
3,5
Debt/Equity
0%
Current Ratio
1,6
Quick Ratio
0,9
Interest Coverage
555,3%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!